$
86.05
10:09 PM EST
Business Description
Laboratorios Farmaceuticos Rovi SA
ISIN : ES0157261019
Description
Financial Strength
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.39 | |||||
Equity-to-Asset | 0.67 | |||||
Debt-to-Equity | 0.12 | |||||
Debt-to-EBITDA | 0.32 | |||||
Interest Coverage | 213.89 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 13.66 | |||||
Beneish M-Score | -2.23 | |||||
WACC vs ROIC |
Growth Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 27.2 | |||||
3-Year EBITDA Growth Rate | 40.1 | |||||
3-Year EPS without NRI Growth Rate | 40.4 | |||||
3-Year FCF Growth Rate | 103.3 | |||||
3-Year Book Growth Rate | 15.6 | |||||
Future 3-5Y Total Revenue Growth Rate | 5 |
Momentum Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 100 | |||||
9-Day RSI | 100 | |||||
14-Day RSI | 99.99 | |||||
6-1 Month Momentum % | 65.48 | |||||
12-1 Month Momentum % | 68.4 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.55 | |||||
Quick Ratio | 0.86 | |||||
Cash Ratio | 0.13 | |||||
Days Inventory | 378.04 | |||||
Days Sales Outstanding | 70.12 | |||||
Days Payable | 131.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 1.64 | |||||
Dividend Payout Ratio | 0.49 | |||||
3-Year Dividend Growth Rate | 94.8 | |||||
Forward Dividend Yield % | 1.64 | |||||
5-Year Yield-on-Cost % | 28.81 | |||||
3-Year Average Share Buyback Ratio | 2.2 | |||||
Shareholder Yield % | 4.32 |
Profitability Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 58.01 | |||||
Operating Margin % | 22.95 | |||||
Net Margin % | 17.69 | |||||
FCF Margin % | 5.83 | |||||
ROE % | 25.57 | |||||
ROA % | 16.05 | |||||
ROIC % | 23.06 | |||||
ROC (Joel Greenblatt) % | 37.77 | |||||
ROCE % | 29.82 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 32.6 | |||||
PE Ratio without NRI | 32.53 | |||||
Shiller PE Ratio | 57.32 | |||||
Price-to-Owner-Earnings | 35.58 | |||||
PEG Ratio | 0.57 | |||||
PS Ratio | 5.77 | |||||
PB Ratio | 8.24 | |||||
Price-to-Tangible-Book | 8.79 | |||||
Price-to-Free-Cash-Flow | 99.02 | |||||
Price-to-Operating-Cash-Flow | 42.88 | |||||
EV-to-EBIT | 24.73 | |||||
EV-to-EBITDA | 21.68 | |||||
EV-to-Revenue | 5.68 | |||||
EV-to-FCF | 98.37 | |||||
Price-to-Projected-FCF | 3.94 | |||||
Price-to-Median-PS-Value | 1.83 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.06 | |||||
Price-to-Graham-Number | 3.21 | |||||
Price-to-Net-Current-Asset-Value | 17.85 | |||||
Earnings Yield (Greenblatt) % | 4.04 | |||||
FCF Yield % | 1.03 | |||||
Forward Rate of Return (Yacktman) % | 21.27 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:LABFF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Laboratorios Farmaceuticos Rovi SA Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 842.779 | ||
EPS (TTM) ($) | 2.842 | ||
Beta | -907.49 | ||
Volatility % | 65.54 | ||
14-Day RSI | 99.99 | ||
14-Day ATR ($) | 0.064414 | ||
20-Day SMA ($) | 86.05 | ||
12-1 Month Momentum % | 68.4 | ||
52-Week Range ($) | 50.88 - 86.05 | ||
Shares Outstanding (Mil) | 51.18 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Laboratorios Farmaceuticos Rovi SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Laboratorios Farmaceuticos Rovi SA Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Laboratorios Farmaceuticos Rovi SA Frequently Asked Questions
What is Laboratorios Farmaceuticos Rovi SA(LABFF)'s stock price today?
When is next earnings date of Laboratorios Farmaceuticos Rovi SA(LABFF)?
Does Laboratorios Farmaceuticos Rovi SA(LABFF) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |